Culture-Expanded Human Invariant Natural Killer T Cells Suppress T-Cell Alloreactivity and Eradicate Leukemia

about

Culture-Expanded Human Invariant Natural Killer T Cells Suppress T-Cell Alloreactivity and Eradicate Leukemia

Item

http://www.wikidata.org/entity/Q58799058

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Culture-Expanded Human Invaria ...... ctivity and Eradicate Leukemia

@en

Culture-Expanded Human Invaria ...... ctivity and Eradicate Leukemia

@nl

type

Item

label

Culture-Expanded Human Invaria ...... ctivity and Eradicate Leukemia

@en

Culture-Expanded Human Invaria ...... ctivity and Eradicate Leukemia

@nl

prefLabel

Culture-Expanded Human Invaria ...... ctivity and Eradicate Leukemia

@en

Culture-Expanded Human Invaria ...... ctivity and Eradicate Leukemia

@nl

P1476

Culture-Expanded Human Invaria ...... ctivity and Eradicate Leukemia

@en

P2093

Corina Schneidawind

http://www.w3.org/2001/XMLSchema#string

Dominik Schneidawind

http://www.w3.org/2001/XMLSchema#string

Felix Kettemann

http://www.w3.org/2001/XMLSchema#string

Hannes Schmid

http://www.w3.org/2001/XMLSchema#string

Hildegard Keppeler

http://www.w3.org/2001/XMLSchema#string

Kathy-Ann Secker

http://www.w3.org/2001/XMLSchema#string

Lothar Kanz

http://www.w3.org/2001/XMLSchema#string

Paul B Savage

http://www.w3.org/2001/XMLSchema#string

Silke Duerr-Stoerzer

http://www.w3.org/2001/XMLSchema#string

Simona Jahnke

http://www.w3.org/2001/XMLSchema#string

P2860

Sustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients.

Antigen-specific cytotoxicity by invariant NKT cells in vivo is CD95/CD178-dependent and is correlated with antigenic potency

Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy.

Efficacy of ABX196, a new NKT agonist, in prophylactic human vaccination

CD4+ invariant natural killer T cells protect from murine GVHD lethality through expansion of donor CD4+CD25+FoxP3+ regulatory T cells.

Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethality.

Interactions between NKT cells and Tregs are required for tolerance to combined bone marrow and organ transplants.

In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets

Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4-dependent mechanism

Invariant natural killer T cells reconstitution and the control of leukemia relapse in pediatric haploidentical hematopoietic stem cell transplantation.

P304

1817

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2018.01817

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30127790

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

P932

6088196

http://www.w3.org/2001/XMLSchema#string